Innovation Analysis Part I
Biotech Series A Up, But Not Synonymous with Innovation
By Trista Morrison
Monday, March 26, 2012
When the number crunchers released their 2011 venture analyses earlier this year, they sparked debate about just how bad – or perhaps good – the fundraising environment for start-up biotechs really was.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.